TR
Live price temporarily unavailable.
Price history
Entrada Therapeutics Inc (TRDA) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: October 29, 2021 · $20.00 offering · NASDAQ · View IPO details →
Recent News (5)
-
Mpm Bioventures 2018 sells $617k Entrada Therapeutics shares
Mpm Bioventures 2018 sells $617k Entrada Therapeutics shares
-
Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics
Mpm Bioventures, 10% owner, sells $617k in Entrada Therapeutics
-
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Mpm Bioventures 2018 sells $615,777 in Entrada Therapeutics stock
Mpm Bioventures 2018 sells $615,777 in Entrada Therapeutics stock
-
Mpm Bioventures 2014 L.P. sells $615,777 of Entrada Therapeutics stock
Mpm Bioventures 2014 L.P. sells $615,777 of Entrada Therapeutics stock
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International